Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Kim YB, et al. Among authors: nikoulina se. J Clin Invest. 1999 Sep;104(6):733-41. doi: 10.1172/JCI6928. J Clin Invest. 1999. PMID: 10491408 Free PMC article.
Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells.
Ciaraldi TP, Nikoulina SE, Bandukwala RA, Carter L, Henry RR. Ciaraldi TP, et al. Among authors: nikoulina se. Endocrinology. 2007 Sep;148(9):4393-9. doi: 10.1210/en.2006-0932. Epub 2007 Jun 14. Endocrinology. 2007. PMID: 17569761
Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR. Nikoulina SE, et al. Diabetes. 2002 Jul;51(7):2190-8. doi: 10.2337/diabetes.51.7.2190. Diabetes. 2002. PMID: 12086949 Free article.
Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation.
Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR. Nikoulina SE, et al. J Clin Endocrinol Metab. 2001 Sep;86(9):4307-14. doi: 10.1210/jcem.86.9.7872. J Clin Endocrinol Metab. 2001. PMID: 11549666
Role of glycogen synthase kinase-3 in skeletal muscle insulin resistance in Type 2 diabetes.
Ciaraldi TP, Nikoulina SE, Henry RR. Ciaraldi TP, et al. Among authors: nikoulina se. J Diabetes Complications. 2002 Jan-Feb;16(1):69-71. doi: 10.1016/s1056-8727(01)00193-3. J Diabetes Complications. 2002. PMID: 11872371 Review. No abstract available.
Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression.
Park KS, Ciaraldi TP, Carter L, Mudaliar S, Nikoulina SE, Webster NJ, Henry RR. Park KS, et al. Among authors: nikoulina se. Metabolism. 2000 Aug;49(8):962-8. doi: 10.1053/meta.2000.7717. Metabolism. 2000. PMID: 10954011
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR. Nikoulina SE, et al. Diabetes. 2000 Feb;49(2):263-71. doi: 10.2337/diabetes.49.2.263. Diabetes. 2000. PMID: 10868943
Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR. Park KS, et al. Among authors: nikoulina se. J Clin Endocrinol Metab. 1998 Aug;83(8):2830-5. doi: 10.1210/jcem.83.8.5034. J Clin Endocrinol Metab. 1998. PMID: 9709955
Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR. Park KS, et al. Among authors: nikoulina se. J Clin Endocrinol Metab. 1998 May;83(5):1636-43. doi: 10.1210/jcem.83.5.4764. J Clin Endocrinol Metab. 1998. PMID: 9589670
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.
Nikoulina SE, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Henry RR. Nikoulina SE, et al. Diabetes. 1997 Jun;46(6):1017-24. doi: 10.2337/diab.46.6.1017. Diabetes. 1997. PMID: 9166674
21 results
Jump to page
Feedback